They gave guidance in 10th Feb announcement..
Looking forward to 2H FY25, the Company expects to see continued growth, some seasonal cost
impacts from patient payment programs as deductibles reset, and an increase in promotional
expenses for Women’s Health products to drive additional growth
- Forums
- ASX - By Stock
- What MYX chart shouts
MYX
mayne pharma group limited
Add to My Watchlist
0.00%
!
$5.22

They gave guidance in 10th Feb announcement.. Looking forward to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.22 |
Change
0.000(0.00%) |
Mkt cap ! $424.1M |
Open | High | Low | Value | Volume |
$5.29 | $5.29 | $5.17 | $18.52K | 3.537K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2471 | $5.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.22 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2471 | 5.150 |
1 | 4000 | 5.140 |
1 | 150 | 5.120 |
3 | 769 | 5.110 |
3 | 1275 | 5.100 |
Price($) | Vol. | No. |
---|---|---|
5.220 | 1 | 1 |
5.230 | 100 | 1 |
5.240 | 300 | 2 |
5.250 | 150 | 1 |
5.260 | 175 | 1 |
Last trade - 10.25am 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online